Skip to content

13F-HR filed by SECTOR GAMMA AS

SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-10, with 33 holding rows worth $545,999,000.

Accession
0001567619-21-009377
Filed
2021-05-10
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2021

A holdings report, 33 entries on the cover page, a total value of $545,999,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $545,999,000 with VALUE read as thousands by filing date, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Pfizer Inc.717081103COM1,365,763$49,482,000thousands by filing date
Gilead Sciences,Inc.375558103COM678,633$43,860,000thousands by filing date
Merck & Co.,Inc.58933Y105COM506,176$39,021,000thousands by filing date
INCYTE CORP COM45337C102Stock341,051$27,717,000thousands by filing date
Medtronic PlcG5960L103COM229,323$27,090,000thousands by filing date
BECTON DICKINSON & CO075887109COM101,787$24,750,000thousands by filing date
BRUKER CORP116794108COM377,767$24,283,000thousands by filing date
Bristol-Myers Squibb Company110122108COM371,062$23,425,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock348,451$22,270,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock454,150$20,419,000thousands by filing date
Elevance Health, Inc.036752103COM56,771$20,378,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM324,464$19,711,000thousands by filing date
NUVASIVE INC670704105COM279,259$18,308,000thousands by filing date
CVS Health Corporation126650100COM239,463$18,015,000thousands by filing date
BAXTER INTL INC071813109COM206,951$17,454,000thousands by filing date
REVVITY INC714046109COM117,467$15,070,000thousands by filing date
Boston Scientific Corporation101137107COM381,536$14,746,000thousands by filing date
BIOGEN INC COM09062X103Stock49,260$13,780,000thousands by filing date
ELANCO ANIMAL HEALTH INC COM28414H103Stock419,979$12,368,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW45,741$11,665,000thousands by filing date
BIO RAD LABS INC090572207CL A19,557$11,170,000thousands by filing date
LIVANOVA PLCG5509L101SHS141,483$10,432,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock59,789$8,442,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock204,878$8,291,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM50,657$7,746,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM91,714$6,925,000thousands by filing date
BIONTECH SE SPONSORED ADS09075V102ADR54,000$5,896,000thousands by filing date
HCA Healthcare Inc40412C101COM29,690$5,592,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK1,530,490$5,234,000thousands by filing date
Johnson & Johnson478160104COM30,000$4,931,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock21,994$2,934,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock4,876$2,307,000thousands by filing date
CUREVAC N VN2451R105COM25,000$2,287,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001567619-21-009377this filing2021-05-10acceptance time not in the bulk data set